Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2020; 4(3): 107-109


Embolization of acquired uterine arteriovenous fistula and pseudoaneurysm as a definitive uterine-sparing treatment

Warren Clements.




Abstract
Cited by 0 Articles

Background: Uterine curettage after spontaneous pregnancy loss may result in complications, including acquired arteriovenous fistula (AVF), and most cases settle spontaneously with conservative or medical management. Persisting symptoms require more definitive treatment and this is usually with hysterectomy. This report shows that the embolization as a uterine-sparing surgical alternative can offer a definitive endovascular treatment strategy.
Case presentation: A 34-year-old lady presented with anemia from recurrent per-vaginal bleeding which persisted for 3 months after curettage for failed early pregnancy. Ultrasound showed AVF and a large pseudoaneurysm. Angiography and embolization was performed using gelatin sponge which was able to successfully treat the vascular lesions. At 2 years follow-up, she had complete symptom resolution and preserved her uterus.
Conclusion: There are only a small number of case reports in the literature to support embolization as a minimally invasive surgical alternative as a definitive treatment.

Key words: Case report, bleeding, fistula, AVF, pseudoaneurysm, hysterectomy, embolization






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.